Ingunn Dybedal
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Subtype-specific outcome after allogeneic hematopoietic cell transplantation in advanced systemic mastocytosis: a registry study of the European competence network on mastocytosis.
Journal: Experimental hematology & oncology
Published: June 21, 2026
Outcomes and prognostic factors in patients with systemic mastocytosis and an associated myeloid neoplasm: an international ECNM registry study.
Journal: Journal of hematology & oncology
Published: March 15, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis.
Journal: The World Allergy Organization journal
Published: May 29, 2025
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study.
Journal: Journal of the American Academy of Dermatology
Published: March 24, 2025
Influence of Cytogenetics on the Outcome of Patients With High-Risk Myelodysplastic Syndrome Including Deletion 5q Treated With Azacitidine With or Without Lenalidomide.
Journal: Genes, chromosomes & cancer
Published: September 05, 2024
Hereditary antithrombin deficiency and venous thrombosis in pregnancy-results of a retrospective multicenter study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 20, 2024
The effect of HLA genotype on disease onset and severity in CTLA-4 insufficiency.
Journal: Frontiers in immunology
Published: June 12, 2024
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.
Journal: HemaSphere
Published: February 17, 2024
Last Updated: 09/26/2026